Continuum Advisory, LLC Kodiak Sciences Inc. Transaction History
Continuum Advisory, LLC
- $773 Million
- Q2 2025
A detailed history of Continuum Advisory, LLC transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Continuum Advisory, LLC holds 14,852 shares of KOD stock, worth $217,581. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,852
Previous 14,852
-0.0%
Holding current value
$217,581
Previous $41,000
34.15%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding KOD
# of Institutions
102Shares Held
41MCall Options Held
73.7KPut Options Held
0-
Baker Bros. Advisors LP New York, NY17.3MShares$254 Million0.65% of portfolio
-
Black Rock Inc. New York, NY3.85MShares$56.4 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.06MShares$30.1 Million0.01% of portfolio
-
Acadian Asset Management LLC Boston, MA1.97MShares$28.9 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.82MShares$26.7 Million0.0% of portfolio
About Kodiak Sciences Inc.
- Ticker KOD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,040,200
- Market Cap $762M
- Description
- Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...